Publications
Detailed Information
The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Min | - |
dc.contributor.author | Ahn, Byung Yong | - |
dc.contributor.author | Lee, Ji Seon | - |
dc.contributor.author | Chung, Sung Soo | - |
dc.contributor.author | Park, Sang Gyu | - |
dc.contributor.author | Lee, Hong Kyu | - |
dc.contributor.author | Park, Kyong Soo | - |
dc.contributor.author | Jung, Hye Seung | - |
dc.contributor.author | Lim, Soo | - |
dc.date.accessioned | 2012-05-23T04:20:44Z | - |
dc.date.available | 2012-05-23T04:20:44Z | - |
dc.date.issued | 2009-11-06 | - |
dc.identifier.citation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Vol.389 1; 70-73 | ko_KR |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://hdl.handle.net/10371/76314 | - |
dc.description.abstract | The ginsenoside Rg3 is known to have a protective effect against hyperglycemia, obesity and diabetes in vivo. In this study, we examined the effect of Rg3 on insulin signaling and glucose uptake in cultured L6 myotubes. Rg3 increased glucose uptake both in the basal and insulin-induced states of L6 myotubes. Consistent with the increase in glucose uptake, Rg3 stimulated the phosphorylation of IRS-1 and Akt. Interestingly, Rg3 dramatically increased IRS-1 protein levels, while the protein level of Akt was not affected. Rg3 regulated IRS-1 expression at the transcriptional level and also increased the level of GLUT4 mRNA. Treatment of ginsam, in which Rg3 is the major compound of ginsenosides, increased the IRS-1 protein levels in OLEFT rats. In addition, we found that this effect of Rg3 on insulin signaling was not mediated by the AMPK pathway. In conclusion, these results suggest that Rg3 improves insulin signaling and glucose uptake primarily by stimulating the expression of IRS-1 and GLUT4. (C) 2009 Elsevier Inc. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | ko_KR |
dc.subject | Rg3 | ko_KR |
dc.subject | Ginsenoside | ko_KR |
dc.subject | IRS-1 | ko_KR |
dc.subject | Insulin signaling | ko_KR |
dc.title | The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김민 | - |
dc.contributor.AlternativeAuthor | 안병용 | - |
dc.contributor.AlternativeAuthor | 이지선 | - |
dc.contributor.AlternativeAuthor | 정성수 | - |
dc.contributor.AlternativeAuthor | 임수 | - |
dc.contributor.AlternativeAuthor | 박상규 | - |
dc.contributor.AlternativeAuthor | 정혜승 | - |
dc.contributor.AlternativeAuthor | 이홍규 | - |
dc.contributor.AlternativeAuthor | 박경수 | - |
dc.identifier.doi | 10.1016/j.bbrc.2009.08.088 | - |
dc.citation.journaltitle | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.description.citedreference | Hwang JT, 2009, PHYTOTHER RES, V23, P262, DOI 10.1002/ptr.2606 | - |
dc.description.citedreference | Lim S, 2009, METABOLISM, V58, P8, DOI 10.1016/j.metabol.2008.07.027 | - |
dc.description.citedreference | Choi KT, 2008, ACTA PHARMACOL SIN, V29, P1109, DOI 10.1111/j.1745-7254.2008.00869.x | - |
dc.description.citedreference | Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334 | - |
dc.description.citedreference | Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200 | - |
dc.description.citedreference | Kim JH, 2005, J PHARMACOL SCI, V97, P124 | - |
dc.description.citedreference | Yun SN, 2004, ARCH PHARM RES, V27, P790 | - |
dc.description.citedreference | Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851 | - |
dc.description.citedreference | Zheng DH, 2001, J APPL PHYSIOL, V91, P1073 | - |
dc.description.citedreference | Cho H, 2001, SCIENCE, V292, P1728 | - |
dc.description.citedreference | Saltiel AR, 2001, CELL, V104, P517 | - |
dc.description.citedreference | CARVALHO E, 2001, FASEB J, V15, P1101 | - |
dc.description.citedreference | Kubota N, 2000, DIABETES, V49, P1880 | - |
dc.description.citedreference | Kido Y, 2000, J CLIN INVEST, V105, P199 | - |
dc.description.citedreference | Blair AS, 1999, J BIOL CHEM, V274, P36293 | - |
dc.description.citedreference | Holmes BF, 1999, J APPL PHYSIOL, V87, P1990 | - |
dc.description.citedreference | Friedman JE, 1999, DIABETES, V48, P1807 | - |
dc.description.citedreference | Wang QH, 1999, MOL CELL BIOL, V19, P4008 | - |
dc.description.citedreference | Virkamaki A, 1999, J CLIN INVEST, V103, P931 | - |
dc.description.citedreference | White MF, 1998, MOL CELL BIOCHEM, V182, P3 | - |
dc.description.citedreference | Gillis CN, 1997, BIOCHEM PHARMACOL, V54, P1 | - |
dc.description.tc | 9 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.